Evidence map›Paper›PMID 34884843›Full record

ArticleInternational journal of molecular sciences2021

BaGdF

Zaira Gadzhimagomedova, Vladimir Polyakov, Ilia Pankin, Vera Butova, Daria Kirsanova, Mikhail Soldatov, Darya Khodakova, Anna Goncharova, Elizaveta Mukhanova, Anna Belanova and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Photo- and X-ray Induced Cytotoxicity of CeFMaterials (Basel, Switzerland) · 2024
    Article
  3. Single-Stage Microfluidic Synthesis Route for BaGdFInternational journal of molecular sciences · 2023
    Article
  4. Synthesis Optimization of BaGdFMaterials (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Zaira GadzhimagomedovaThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.ORCID 0000-0003-4881-5383
Vladimir PolyakovThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.ORCID 0000-0002-6774-8983
Ilia PankinThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.
Vera ButovaThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.ORCID 0000-0002-4099-0737
Daria KirsanovaThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.ORCID 0000-0003-1863-0927
Mikhail SoldatovThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.ORCID 0000-0003-1918-7875
Darya KhodakovaNational Medical Research Centre for Oncology, 344037 Rostov-on-Don, Russia.
Anna GoncharovaNational Medical Research Centre for Oncology, 344037 Rostov-on-Don, Russia.
Elizaveta MukhanovaThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.
Anna BelanovaAcademy of Biology and Biotechnologies, Southern Federal University, 344090 Rostov-on-Don, Russia.
Aleksey MaksimovNational Medical Research Centre for Oncology, 344037 Rostov-on-Don, Russia.
Alexander SoldatovThe Smart Materials Research Institute, Southern Federal University, 344090 Rostov-on-Don, Russia.
Southern Federal University · RURostov Research Institute of Oncology · RU

Funding

Russian Science Foundation 19-15-00305
6 · The paper itself

Abstract

X-ray photodynamic therapy (XPDT) has been recently considered as an efficient alternative to conventional radiotherapy of malignant tissues. Nanocomposites for XPDT typically consist of two components-a nanophosphor which re-emits X-rays into visible light that in turn is absorbed by the second component, a photosensitizer, for further generation of reactive oxygen species. In this study, BaGdF

Indexed as

BariumCell SurvivalContrast MediaCrystallography, X-RayEuropiumGadoliniumHeLa CellsHumansNanocompositesParticle SizePhotochemotherapyPhotosensitizing AgentsSilicon DioxideX-RaysBariumContrast MediaEuropiumGadoliniumPhotosensitizing AgentsSilicon Dioxidecomputed tomographynanophosphorphotosensitizerreactive oxygen speciesscintillating nanoparticlestumorX-ray photodynamic therapy

Identifiers

PMID34884843
PMCPMC8657490
OpenAlexW3216339526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.